Follow
Ruud Dings
Title
Cited by
Cited by
Year
Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy
VLJL Thijssen, R Postel, RJ Brandwijk, RPM Dings, I Nesmelova, S Satijn, ...
Proceedings of the National Academy of Sciences 103 (43), 15975-15980, 2006
5772006
Consensus guidelines for the use and interpretation of angiogenesis assays
P Nowak-Sliwinska, K Alitalo, E Allen, A Anisimov, AC Aplin, R Auerbach, ...
Angiogenesis 21, 425-532, 2018
5432018
Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization
RPM Dings, M Loren, H Heun, E McNiel, AW Griffioen, KH Mayo, ...
Clinical Cancer Research 13 (11), 3395-3402, 2007
3392007
Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells
CW Song, H Lee, RPM Dings, B Williams, J Powers, TD Santos, BH Choi, ...
Scientific reports 2 (1), 362, 2012
3252012
Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculature
JR Van Beijnum, RP Dings, E Van Der Linden, BMM Zwaans, ...
Blood 108 (7), 2339-2348, 2006
3052006
Anti‐angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte‐endothelium interactions and infiltration in tumors
AEM Dirkx, MGA Egbrink, K Castermans, DWJ Van Der Schaft, ...
The FASEB Journal 20 (6), 621-630, 2006
2732006
Epigenetic regulation of tumor endothelial cell anergy: silencing of intercellular adhesion molecule-1 by histone modifications
DMEI Hellebrekers, K Castermans, E Viré, RPM Dings, NTH Hoebers, ...
Cancer research 66 (22), 10770-10777, 2006
1612006
Antitumor agent calixarene 0118 targets human galectin-1 as an allosteric inhibitor of carbohydrate binding
RPM Dings, MC Miller, I Nesmelova, L Astorgues-Xerri, N Kumar, ...
Journal of medicinal chemistry 55 (11), 5121-5129, 2012
1332012
The designed angiostatic peptide anginex synergistically improves chemotherapy and antiangiogenesis therapy with angiostatin
RPM Dings, Y Yokoyama, S Ramakrishnan, AW Griffioen, KH Mayo
Cancer research 63 (2), 382-385, 2003
1282003
Galectins as molecular targets for therapeutic intervention
RPM Dings, MC Miller, RJ Griffin, KH Mayo
International journal of molecular sciences 19 (3), 905, 2018
1212018
Design of nonpeptidic topomimetics of antiangiogenic proteins with antitumor activities
RPM Dings, X Chen, DMEI Hellebrekers, LI van Eijk, Y Zhang, TR Hoye, ...
Journal of the National Cancer Institute 98 (13), 932-936, 2006
1192006
The designer antiangiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models
DWJ van der Schaft, RPM Dings, QG de Lussanet, LI van Eijk, AW Nap, ...
The FASEB journal 16 (14), 1991-1993, 2002
1172002
Angiogenesis gene expression profiling in xenograft models to study cellular interactions
VLJL Thijssen, RJ Brandwijk, RPM Dings, AW Griffioen
Experimental cell research 299 (2), 286-293, 2004
1032004
Anginex synergizes with radiation therapy to inhibit tumor growth by radiosensitizing endothelial cells
RPM Dings, BW Williams, CW Song, AW Griffioen, KH Mayo, RJ Griffin
International journal of cancer 115 (2), 312-319, 2005
1002005
Glutaminase inhibitor CB-839 increases radiation sensitivity of lung tumor cells and human lung tumor xenografts in mice
G Boysen, A Jamshidi-Parsian, MA Davis, ER Siegel, CM Simecka, ...
International journal of radiation biology 95 (4), 436-442, 2019
902019
Mild temperature hyperthermia and radiation therapy: role of tumour vascular thermotolerance and relevant physiological factors
RJ Griffin, RPM Dings, A Jamshidi-Parsian, CW Song
International Journal of Hyperthermia 26 (3), 256-263, 2010
882010
Hypoxia-derived exosomes induce putative altered pathways in biosynthesis and ion regulatory channels in glioblastoma cells
RA Kore, JL Edmondson, SV Jenkins, A Jamshidi-Parsian, RPM Dings, ...
Biochemistry and biophysics reports 14, 104-113, 2018
842018
Enhancement of T-cell–Mediated Antitumor Response: Angiostatic Adjuvant to Immunotherapy against Cancer
RPM Dings, KB Vang, K Castermans, F Popescu, Y Zhang, ...
Clinical Cancer Research 17 (10), 3134-3145, 2011
812011
Anti-tumor activity of the novel angiogenesis inhibitor anginex
RPM Dings, DWJ Van Der Schaft, B Hargittai, J Haseman, AW Griffioen, ...
Cancer letters 194 (1), 55-66, 2003
812003
Design of a partial peptide mimetic of anginex with antiangiogenic and anticancer activity
KH Mayo, RPM Dings, C Flader, I Nesmelova, B Hargittai, ...
Journal of Biological Chemistry 278 (46), 45746-45752, 2003
802003
The system can't perform the operation now. Try again later.
Articles 1–20